TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
TCL Archive House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase June 18, 1993
TCL Archive In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford March 11, 1977
